Literature DB >> 31508974

Characterization of cystic fibrosis airway smooth muscle cell proliferative and contractile activities.

Joyce Hojin Jang1,2, Alice Panariti1, Michael J O'Sullivan1, Melissa Pyrch1, Chris Wong1, Anne-Marie Lauzon1,2, James G Martin1,2.   

Abstract

Cystic fibrosis (CF) is a genetic disease that causes multiple airway abnormalities. Two major respiratory consequences of CF are airway hyperresponsiveness (AHR) and airway remodeling. Airway smooth muscle (ASM) is hypothesized to be responsible for the airway dysfunction, since their thickening is involved in remodeling, and excessive contraction by the ASM may cause AHR. It is unclear whether the ASM is intrinsically altered to favor increased contractility or proliferation or if microenvironmental influences induce pathological behavior in vivo. In this study, we examined the contractile and proliferative properties of ASM cells isolated from healthy donor and CF transplant lungs. Assays of proliferation showed that CF ASM proliferates at a higher rate than healthy cells. Through calcium analysis, no differences in contractile activation in response to histamine were found. However, CF ASM cells lagged in their reuptake of calcium in the sarcoplasmic reticulum. The combination CFTR corrector and potentiator, VX-809/770, used to restore CFTR function in CF ASM, resulted in a reduction in proliferation and in a normalization of calcium reuptake kinetics. These results show that impaired CFTR function in ASM cells causes intrinsic changes in their proliferative and contractile properties.

Entities:  

Keywords:  CFTR; calcium; hyperresponsiveness; remodeling; vertex

Mesh:

Substances:

Year:  2019        PMID: 31508974     DOI: 10.1152/ajplung.00090.2019

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  1 in total

1.  Prevalence and Determinants of Wheezing and Bronchodilatation in Children With Cystic Fibrosis: A Retrospective Cohort Study.

Authors:  Francois Galodé; O Ladipo; A Andrieux; H Feghali; S Bui; Michael Fayon
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.